NICE stands firm, but the public must learn to respect rationing
When the High Court upheld NICE guidance on Alzheimer's drugs, it was seen as an endorsement of its fairness and credibility. But unless the public is better informed of resource issues, unrealistic demands for new drugs will continue to be an issue, writes Helen Mooney
You need to be a subscriber to read more
Subscribe for unlimited access
With a HSJ subscription you’ll unlock:
- All HSJ news by sector, topic & region
- Breaking News announcements
- App for mobile and offline reading
- Comment and Daily Insights newsletters
- Regional roundup newsletters
- 10 expert briefings every fortnight (Premium only)
- Unrestricted access to ‘Ask HSJ’ - AI assistant - AI assistant (Premium only)
Already a subscriber? Sign into your account here